Volume 6, Issue 8

Promising New Options in MS Care

In this issue:

The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future.

Join us as we discuss the current state of this exciting research with Drs. Cole Harrington and Nikhil Modak from the Department of Neurology at The Ohio State University Wexner Medical Center, in this issue of eMultipleSclerosis Review.

 

 

Learning objective:

Describe safety and efficacy of treatment for MS that are newly available or in development. 

Authors:

Cole Harrington, MD, PhD
Cole Harrington, MD, PhD

Assistant Professor in Neurology
Department of Neurology
The Ohio State University Wexner Medical Center
Columbus, OH

Nikhil Modak, MD
Nikhil Modak, MD

Neuroimmunology Fellow
The Ohio State University
Columbus, OH

Program Directors:

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Pavan Bhargava, MBBS, MD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Lisa Fox, PA-C, MPAS

Department of Neurology
Johns Hopkins Hospital
Baltimore, MD

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: January 17, 2025
Expiration date: January 16, 2027